Magnolia Medical Technologies, Inc. v. Kurin, Inc.

Case Summary

This case involves a patent dispute between Magnolia Medical Technologies, Inc. (Magnolia) and Kurin, Inc. (Kurin) concerning devices designed to divert initial blood flow during venipuncture to prevent contamination of blood samples. Magnolia sued Kurin for infringing its U.S. Patent No. 9,186,041 ('041 patent). The district court initially found that Kurin's devices did not infringe Magnolia's patent and that certain claims of Magnolia's patent were invalid as obvious. Magnolia appealed these decisions. The Court of Appeals for the Federal Circuit (CAFC) reviewed the district court's findings. The CAFC affirmed the district court's decision that Kurin did not infringe Magnolia's patent. However, the CAFC reversed the district court's finding that claims 1 and 10 of the '041 patent were invalid due to obviousness. This means that while Kurin is not infringing, the patent claims themselves are still considered valid. The case was sent back to the district court for further proceedings consistent with the CAFC's ruling regarding the patent's validity.

AI-generated summary for informational purposes only. Not legal advice. May contain errors. Consult a licensed attorney for legal advice.

Key Holdings

The court established the following key holdings in this case:

1. The district court's finding of non-infringement by Kurin's devices was affirmed.
2. The district court's finding that claims 1 and 10 of U.S. Patent No. 9,186,041 were invalid as obvious was reversed.

Entities and Participants

Frequently Asked Questions (4)

Comprehensive Q&A covering every aspect of this court opinion.

Basic Questions (4)

Case Details

Related Legal Resources

About This Analysis

This AI-generated analysis of Magnolia Medical Technologies, Inc. v. Kurin, Inc. was produced by CaseLawBrief to help legal professionals, researchers, students, and the general public understand this court opinion in plain English.

CaseLawBrief aggregates court opinions from CourtListener, a project of the Free Law Project, and enriches them with AI-powered analysis. Our goal is to make the law more accessible and understandable to everyone, regardless of their legal background.

AI-generated summary for informational purposes only. Not legal advice. May contain errors. Consult a licensed attorney for legal advice.

Related Cases

Other opinions on patent-infringement or from the Federal Circuit:

• Vlsi Technology LLC v. Intel Corporation
  Federal Circuit Affirms Patent Infringement, Reverses Damages Award
  Federal Circuit · 2026-04-14
• Practical Technology, Inc. v. Neurological Fitness Equipment and Education, LLC
  Patent invalidity and no trade secret misappropriation affirmed
  Texas Court of Appeals · 2026-04-10
• Radial Power Asset, LLC v. UNIRAC,Inc
  Appellate court affirms patent infringement ruling and royalty award
  Texas Court of Appeals · 2026-04-09
• Kendall v. Collins
  Federal Circuit Affirms No Patent Infringement Under Doctrine of Equivalents
  Federal Circuit · 2026-03-31
• MacKey v. Collins
  Federal Circuit Finds No Patent Infringement Under Doctrine of Equivalents
  Federal Circuit · 2026-03-30
• Ascendis Pharma A/S v. Biomarin Pharmaceutical Inc.
  Appeals Court Affirms Non-Infringement Ruling in Patent Dispute Over Dwarfism Drug
  Federal Circuit · 2026-03-26
• Crafted Audio, LLC v. Clair Global Integration, LLC
  Appellate Court Affirms Summary Judgment for Defendant in Patent Infringement Case
  Florida District Court of Appeal · 2026-03-20
• Apple Inc. v. Itc
  CAFC Affirms in Part, Reverses in Part ITC Ruling Against Apple in Patent Infringement Case, Remands for Further Proceedings
  Federal Circuit · 2026-03-19